Navigation Links
Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, Poland
Date:9/10/2013

ROCKVILLE, Md., Sept. 10, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that Jeffrey Riley, CEO, will present at the First Global Life Sciences Conference to be held on September 16-17, 2013 in Warsaw, Poland. Mr. Riley is scheduled to present at 11:15 a.m. (Central European Summer Time)/5:15 a.m. (Eastern Time) on Monday, September 16, 2013 at the Warsaw Stock Exchange.

(Logo: http://photos.prnewswire.com/prnh/20130522/MM19465LOGO )

A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the internet at http://www.wdmcapital.com/en/strony/lsc/live_webcast.html. After the presentation, a replay will be archived and accessible for 30 days at the same website.

Mr. Riley, as well as Synthetic Biologics' CFO, C. Evan Ballantyne, will be available to participate in one-on-one meetings with conference attendees. To arrange a one-on-one meeting with Synthetic Biologics, please contact Wojciech Grzegorczyk at wojciech.grzegorczyk@wdmsa.pl or by phone +48 784 094 599.

WDM Capital, a prominent small cap investment bank in Central and Eastern Europe, is organizing the conference in partnership with the Warsaw Stock Exchange and Deloitte. For more information visit: http://lscwarsaw.com.

About Synthetic Biologics, Inc.

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a biotechnology company focused on the development of biologics for the prevention and treatment of serious inf
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
3. Synthetic Biologics Reports Second Quarter 2012 Financial Results
4. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
5. The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC
6. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
7. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
8. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
9. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
10. Synthetic Biologics to Present at the 25th Annual ROTH Conference
11. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
(Date:1/22/2015)...  Profil Institute for Clinical Research, Inc., a clinical research ... a new textbook,  Translational Research Methods for Diabetes, Obesity ... global scientific publisher. The textbook is the ... in early phase clinical studies of new drugs for ...
Breaking Medicine Technology:BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... (Nasdaq: OPTR ) today announced that the Company ... June 8, 2011 at 11:00 a.m. Eastern Time at The ... http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ) A live audio webcast of this ... Company,s website at www.optimerpharma.com . Replays of this presentation ...
... Va., June 1, 2011 Mirixa Corporation is pleased ... a licensing agreement for MirixaEdge(SM), a clinical application that ... Medication Therapy Management (MTM). Family Physicians Group ... One Source Pharmacy and selected it as FPG,s preferred ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3
(Date:1/22/2015)... 22, 2015 Deer Path of Huntley ... Valentine’s Day Happy Hour from 3 p.m. to 4 p.m. on ... Parkway in Huntley, Illinois, serves adults with physical disabilities between the ... include Valentine's Day treats, games and sweetheart-themed karaoke. , For more ...
(Date:1/22/2015)... its top dressmaking technologies, has been a leading dress supplier ... latest designs of wedding dresses and launching a site-wide promotion ... the fresh new products are designed for 2015, and they ... All the clothes from LunaDress follow up with the latest ...
(Date:1/22/2015)... January 22, 2015 Gabe’s Chemo Duck Program is ... the first app ever created for kids with cancer. The Chemo ... and devices, is filled with enjoyable games to help children of ... The free app helps to keep kids entertained, educated and at ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together ... by up to 30lbs in less than 12 weeks without ... Stevenson, prompting an investigative review. , “Our Incredible Bulk ... formula that allows the body to pack on a massive ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has ... View website of AngelWeddingDress.com to find more ... dresses online for a bridal party. AngelWeddingDress offers a ... them. Its maternity wedding dresses are specially designed for ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... Reporter , TUESDAY, July 20 (HealthDay News) -- The ... chemotherapy, is safe and can effectively treat an advanced ... researchers report. Previously it had been thought that ... life-threatening bleeding, for patients with non-squamous non-small-cell lung tumors. ...
... New Haven, onn. - A team of Yale researchers have identified ... ovarian cancer, a hard to detect and often deadly form of ... journal Cancer Research, the team showed that a variant ... ovarian cancer patients. In addition, this variant was found in 61 ...
... Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible ... more likely today, Lady Gaga -- only hint at ... Now a data-driven review by Northwestern University researchers ... Reviews Neuroscience pulls together converging research from the ...
... the Law Center and Graduate College of Social Work ... Student of the Year by the National Association of Social ... 9 at the organization,s annual conference at the Westin Galleria ... graduate or undergraduate student enrolled in a social work program ...
... COLUMBIA, Mo. ... illicit drug use among all ethnic groups. Although previous ... factors can reduce their risk for substance abuse, this ... findings from a University of Missouri study reveal that ...
... Conference in Vienna are charging developed and developing country ... of people in need of lifesaving HIV treatment. ... the International Treatment Preparedness Coalition,s (ITPC), latest report, Rationing ... pullback on AIDS commitment and funding: caps on the ...
Cached Medicine News:Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 2Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 3Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 4Health News:Yale scientists discover new genetic marker of ovarian cancer risk 2Health News:Taking music seriously 2Health News:Taking music seriously 3Health News:University of Houston's Meghan Baker named Social Work Student of the Year in Texas 2Health News:Healthy families, religious involvement buffer youth against risk factors related to drug abuse 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 3Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 4Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 5
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
... of guiding introducers includes Swartz™ Series, ... piece steerable, all designed for the ... varying curves and longer sheath lengths ... Jude Medical guiding introducers are designed ...
Novus 30001 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
... 1064 nm Nd:YAG Base Platform ... ophthalmologists treating the anterior segment ... the elimination of secondary cataracts ... Selecta platform offers multiple upgrade ...
Medicine Products: